- Home
- CBAN vs ARCT Comparison
CBAN vs ARCT Comparison
Compare CBAN & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAN
- ARCT
- Stock Information
- Founded
- CBAN 1975
- ARCT 2013
- Country
- CBAN United States
- ARCT United States
- Employees
- CBAN N/A
- ARCT N/A
- Industry
- CBAN Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CBAN Finance
- ARCT Health Care
- Exchange
- CBAN Nasdaq
- ARCT Nasdaq
- Market Cap
- CBAN 285.4M
- ARCT 298.3M
- IPO Year
- CBAN 1998
- ARCT N/A
- Fundamental
- Price
- CBAN $15.29
- ARCT $12.53
- Analyst Decision
- CBAN
- ARCT Strong Buy
- Analyst Count
- CBAN 0
- ARCT 8
- Target Price
- CBAN N/A
- ARCT $52.33
- AVG Volume (30 Days)
- CBAN 56.2K
- ARCT 450.8K
- Earning Date
- CBAN 07-23-2025
- ARCT 05-12-2025
- Dividend Yield
- CBAN 3.01%
- ARCT N/A
- EPS Growth
- CBAN 14.66
- ARCT N/A
- EPS
- CBAN 1.43
- ARCT N/A
- Revenue
- CBAN $113,756,000.00
- ARCT $143,680,000.00
- Revenue This Year
- CBAN $18.25
- ARCT N/A
- Revenue Next Year
- CBAN $7.59
- ARCT $42.36
- P/E Ratio
- CBAN $10.67
- ARCT N/A
- Revenue Growth
- CBAN 3.33
- ARCT 15.38
- 52 Week Low
- CBAN $11.26
- ARCT $8.04
- 52 Week High
- CBAN $18.49
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CBAN 45.90
- ARCT 54.31
- Support Level
- CBAN $14.63
- ARCT $11.51
- Resistance Level
- CBAN $15.80
- ARCT $13.00
- Average True Range (ATR)
- CBAN 0.40
- ARCT 0.98
- MACD
- CBAN -0.09
- ARCT 0.08
- Stochastic Oscillator
- CBAN 36.67
- ARCT 57.74
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.